Search
Descriptor English: Glucagonoma
Descriptor Spanish: Glucagonoma
Descriptor glucagonoma
Entry term(s) adenoma de células alfa
tumor de células alfa
Scope note: Tumor derivado de las CÉLULAS PANCREATICAS ALFA, secretoras de GLUCAGÓN, casi siempre maligno. Se caracteriza por ERITEMA migratorio típico, PÉRDIDA DE PESO, ESTOMATITIS, GLOSITIS, DIABETES MELLITUS, hipoaminoacidemia, y ANEMIA normocítica normocrómica.
Descriptor Portuguese: Glucagonoma
Descriptor French: Glucagonome
Entry term(s): Adenoma, alpha Cell
Adenoma, alpha-Cell
Adenomas, alpha-Cell
Glucagonoma Syndrome
Glucagonoma Syndromes
Glucagonomas
Syndrome, Glucagonoma
Syndromes, Glucagonoma
Tumor, alpha-Cell
Tumors, alpha-Cell
alpha Cell Tumor
alpha-Cell Adenoma
alpha-Cell Adenomas
alpha-Cell Tumor
alpha-Cell Tumors
Tree number(s): C04.557.470.200.025.290.750
C04.588.274.761.500.249
C04.588.322.475.500.249
C06.301.761.500.249
C06.689.667.500.249
C19.344.421.500.249
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D005935
Scope note: An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
Annotation: coordinate IM with PANCREATIC NEOPLASMS (IM); for glucagonoma syndrome, coordinate also with NECROLYTIC MIGRATORY ERYTHEMA
Allowable Qualifiers: BL blood
BS blood supply
CF cerebrospinal fluid
CH chemistry
CI chemically induced
CL classification
CN congenital
CO complications
DG diagnostic imaging
DH diet therapy
DI diagnosis
DT drug therapy
EC economics
EH ethnology
EM embryology
EN enzymology
EP epidemiology
ET etiology
GE genetics
HI history
IM immunology
ME metabolism
MI microbiology
MO mortality
NU nursing
PA pathology
PC prevention & control
PP physiopathology
PS parasitology
PX psychology
RH rehabilitation
RT radiotherapy
SC secondary
SU surgery
TH therapy
UL ultrastructure
UR urine
VE veterinary
VI virology
Previous Indexing: Islet Cell Tumor (1966-1981)
Public MeSH Note: 91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981
Online Note: search ISLET CELL TUMOR 1981
History Note: 91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981
Related: Necrolytic Migratory Erythema MeSH
DeCS ID: 6079
Unique ID: D005935
NLM Classification: WI 810
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1981/05/20
Revision Date: 2012/07/03
Glucagonoma - Preferred
Concept UI M0009315
Scope note An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
Preferred term Glucagonoma
Entry term(s) Adenoma, alpha Cell
Adenoma, alpha-Cell
Adenomas, alpha-Cell
Glucagonoma Syndrome
Glucagonoma Syndromes
Glucagonomas
Syndrome, Glucagonoma
Syndromes, Glucagonoma
Tumor, alpha-Cell
Tumors, alpha-Cell
alpha Cell Tumor
alpha-Cell Adenoma
alpha-Cell Adenomas
alpha-Cell Tumor
alpha-Cell Tumors



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey